Todor Dentchev

605 total citations
13 papers, 441 citations indexed

About

Todor Dentchev is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Todor Dentchev has authored 13 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Hematology. Recurrent topics in Todor Dentchev's work include Cancer Treatment and Pharmacology (7 papers), Colorectal Cancer Treatments and Studies (4 papers) and Bone health and treatments (3 papers). Todor Dentchev is often cited by papers focused on Cancer Treatment and Pharmacology (7 papers), Colorectal Cancer Treatments and Studies (4 papers) and Bone health and treatments (3 papers). Todor Dentchev collaborates with scholars based in United States and Belgium. Todor Dentchev's co-authors include Charles L. Loprinzi, Jeff A. Sloan, Daniel A. Nikcevich, Steven R. Alberts, Peter T. Silberstein, Paul J. Novotny, Donald B. Wender, John W. Kugler, Axel Grothey and Paul Schaefer and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Breast Cancer Research and Treatment.

In The Last Decade

Todor Dentchev

13 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Todor Dentchev United States 8 365 82 79 76 56 13 441
Yonghong Dang China 14 98 0.3× 7 0.1× 27 0.3× 95 1.3× 22 0.4× 33 403
F. Figus Italy 7 43 0.1× 10 0.1× 64 0.8× 37 0.5× 12 0.2× 11 400
Lucas Vieira dos Santos Brazil 13 233 0.6× 57 0.7× 9 0.1× 150 2.0× 9 0.2× 33 471
Francesca De Iuliis Italy 9 198 0.5× 46 0.6× 19 0.2× 64 0.8× 1 0.0× 17 317
Emma V. Morris United Kingdom 10 133 0.4× 6 0.1× 111 1.4× 40 0.5× 2 0.0× 14 374
Amar Mahgoub United States 9 88 0.2× 8 0.1× 21 0.3× 62 0.8× 15 0.3× 18 401
Mario Nicolini Italy 10 134 0.4× 15 0.2× 17 0.2× 115 1.5× 6 0.1× 20 277
Laura Mastrangelo Italy 6 99 0.3× 26 0.3× 4 0.1× 71 0.9× 31 0.6× 10 297
Renfang Han China 14 25 0.1× 9 0.1× 58 0.7× 39 0.5× 9 0.2× 27 404

Countries citing papers authored by Todor Dentchev

Since Specialization
Citations

This map shows the geographic impact of Todor Dentchev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todor Dentchev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todor Dentchev more than expected).

Fields of papers citing papers by Todor Dentchev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todor Dentchev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todor Dentchev. The network helps show where Todor Dentchev may publish in the future.

Co-authorship network of co-authors of Todor Dentchev

This figure shows the co-authorship network connecting the top 25 collaborators of Todor Dentchev. A scholar is included among the top collaborators of Todor Dentchev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todor Dentchev. Todor Dentchev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Pachman, Deirdre R., Travis Dockter, Patricia J. Zekan, et al.. (2017). A pilot study of minocycline for the prevention of paclitaxel-associated neuropathy: ACCRU study RU221408I. Supportive Care in Cancer. 25(11). 3407–3416. 50 indexed citations
2.
Pachman, Deirdre R., Travis Dockter, Patricia J. Zekan, et al.. (2016). Pilot study of minocycline for the prevention of paclitaxel-associated neuropathy: ACCRU RU221408I.. Journal of Clinical Oncology. 34(26_suppl). 220–220. 1 indexed citations
3.
4.
Grothey, Axel, Daniel A. Nikcevich, Jeff A. Sloan, et al.. (2010). Intravenous Calcium and Magnesium for Oxaliplatin-Induced Sensory Neurotoxicity in Adjuvant Colon Cancer: NCCTG N04C7. Journal of Clinical Oncology. 29(4). 421–427. 141 indexed citations
5.
Perez, Edith A., David W. Hillman, Todor Dentchev, et al.. (2009). North Central Cancer Treatment Group (NCCTG) N0432: phase II trial of docetaxel with capecitabine and bevacizumab as first-line chemotherapy for patients with metastatic breast cancer. Annals of Oncology. 21(2). 269–274. 29 indexed citations
6.
Grothey, Axel, Daniel A. Nikcevich, Jeff A. Sloan, et al.. (2009). Evaluation of the effect of intravenous calcium and magnesium (CaMg) on chronic and acute neurotoxicity associated with oxaliplatin: Results from a placebo-controlled phase III trial. Journal of Clinical Oncology. 27(15_suppl). 4025–4025. 4 indexed citations
7.
Kearns, Ann E., Donald W. Northfelt, Amylou C. Dueck, et al.. (2009). Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8. Supportive Care in Cancer. 18(3). 321–328. 19 indexed citations
8.
Hines, Stephanie L., Betty A. Mincey, Todor Dentchev, et al.. (2009). Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC. Breast Cancer Research and Treatment. 117(3). 603–609. 66 indexed citations
9.
Nikcevich, Daniel A., Axel Grothey, Jeff A. Sloan, et al.. (2008). Effect of intravenous calcium and magnesium (IV CaMg) on oxaliplatin-induced sensory neurotoxicity (sNT) in adjuvant colon cancer: Results of the phase III placebo-controlled, double-blind NCCTG trial N04C7. Journal of Clinical Oncology. 26(15_suppl). 4009–4009. 29 indexed citations
10.
11.
Steensma, David P., R Molina, Jeff A. Sloan, et al.. (2006). Phase III Study of Two Different Dosing Schedules of Erythropoietin in Anemic Patients With Cancer. Journal of Clinical Oncology. 24(7). 1079–1089. 37 indexed citations
12.
Johnson, Elizabeth A., Randolph S. Marks, Sumithra J. Mandrekar, et al.. (2005). A phase III randomized placebo controlled NCCTG trial of carboxyaminoimidazole (CAI) in patients with advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 23(16_suppl). 7054–7054. 1 indexed citations
13.
Steensma, David P., R Molina, Jeff A. Sloan, et al.. (2005). A phase III randomized trial of two different dosing schedules of erythropoietin (EPO) in patients with cancer-associated anemia: North Central Cancer Treatment Group (NCCTG) Study N02C2. Journal of Clinical Oncology. 23(16_suppl). 8031–8031. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yonghong Dang Breakdown of academic impact, for papers by F. Figus Breakdown of academic impact, for papers by Lucas Vieira dos Santos Breakdown of academic impact, for papers by Francesca De Iuliis Breakdown of academic impact, for papers by Emma V. Morris Breakdown of academic impact, for papers by Amar Mahgoub Breakdown of academic impact, for papers by Mario Nicolini Breakdown of academic impact, for papers by Laura Mastrangelo Breakdown of academic impact, for papers by Renfang Han
Rankless by CCL
2026